Rare diseases and orphan drugs regulatory framework in Canada
PRA Health Sciences | Blog
by
10M ago
This blog details initiatives that are being taken by the Government of Canada to promote a health care system that works for those with rare disorders ..read more
Visit website
Biotech’s evolving relationship with CROs
PRA Health Sciences | Blog
by
11M ago
In this blog, read more on recent trends and learn why strategic outsourcing is a key opportunity ..read more
Visit website
Improving the experience of healthy volunteers during early phase clinical trials
PRA Health Sciences | Blog
by
11M ago
How ICON’s application of a volunteer-centric approach is improving recruitment and retention rates of healthy participants in early phase studies ..read more
Visit website
From clinician visits to data analysis: the challenges and solutions in COVID vaccine pharmacovigilance
PRA Health Sciences | Blog
by
1y ago
Learn more about the challenges and solutions in assessing the long-term effects of Covid and Covid vaccines in this blog ..read more
Visit website
Use of ddPCR and qPCR assays for PK and safety monitoring in Cell & Gene Therapy clinical trials
PRA Health Sciences | Blog
by
1y ago
Immunotherapy technologies are rapidly advancing, as are the methods of ensuring their safety and reliability. ICON explores the tools used in CGT trials ..read more
Visit website
How data science is changing the face of healthcare
PRA Health Sciences | Blog
by
1y ago
In this podcast, Michael Goedde shares his journey in technology and his role in building the digital platform for healthcare systems at ICON ..read more
Visit website
Mary O’Reilly reflects on International Women’s Day
PRA Health Sciences | Blog
by
1y ago
In this blog, Mary O’Reilly reflects on the International Women’s Day panel and events held at ICON’s global headquarters in Dublin ..read more
Visit website
A positive step for diversity and inclusion in clinical trials – reflections on FDORA
PRA Health Sciences | Blog
by
1y ago
Read this blog for updated recommendations and additional guidance on DCTs to ensure equitable access to cutting-edge therapeutics and clinical trials ..read more
Visit website
Rare Disease Day diversity and inclusion
PRA Health Sciences | Blog
by
1y ago
This event aims to raise awareness about the diversity of individuals affected by rare diseases. Find out how virtual events can be made more accessible and inclusive ..read more
Visit website
My patient story - Chelsea Mason
PRA Health Sciences | Blog
by
1y ago
ICON's Chelsea Mason shares her personal experiences with cancer ..read more
Visit website

Follow PRA Health Sciences | Blog on FeedSpot

Continue with Google
Continue with Apple
OR